APA (7th ed.) Citation

Cheng, L., Kankam, M., Siebers, N., Stoltz, R., Abuqayyas, L., Ertik, B., . . . Parnes, J. (2018). AB0521 Safety, pharmacokinetics, and pharmacodynamics of single doses of a bispecific icosl and baff inhibitor, amg 570, in healthy subjects. Annals of the rheumatic diseases, 77(Suppl 2), 1418. https://doi.org/10.1136/annrheumdis-2018-eular.2956

Chicago Style (17th ed.) Citation

Cheng, L.E, et al. "AB0521 Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of a Bispecific Icosl and Baff Inhibitor, Amg 570, in Healthy Subjects." Annals of the Rheumatic Diseases 77, no. Suppl 2 (2018): 1418. https://doi.org/10.1136/annrheumdis-2018-eular.2956.

MLA (9th ed.) Citation

Cheng, L.E, et al. "AB0521 Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of a Bispecific Icosl and Baff Inhibitor, Amg 570, in Healthy Subjects." Annals of the Rheumatic Diseases, vol. 77, no. Suppl 2, 2018, p. 1418, https://doi.org/10.1136/annrheumdis-2018-eular.2956.